Description
What Is the CJC-1295 + Ipamorelin Blend?
This is a pre-mixed 10mg vial containing 5mg of CJC-1295 (No DAC) and 5mg of Ipamorelin — the two peptides researchers most commonly pair, already combined in a fixed 1:1 ratio. One vial. One reconstitution. Both compounds in every draw, every time. Each component is independently HPLC-verified at ≥99% purity before formulation, with batch-specific Certificate of Analysis available.
Why Researchers Choose the Pre-Mixed Blend
- Single-vial convenience: Both peptides are already combined — every unit drawn contains equal parts of each. Eliminates a separate preparation step compared to reconstituting two vials individually.
- Fixed 1:1 ratio: Pre-formulated at 5mg + 5mg so the ratio between compounds stays consistent across the entire vial — no measuring and combining at the bench.
- Streamlined storage: One reconstituted vial in the fridge instead of two; one expiration date to track.
- Independently verified components: CJC-1295 (No DAC) and Ipamorelin are each HPLC-tested at ≥99% purity before being combined into the blend.
- The most-paired GH research combination: A GHRH analog (CJC-1295 No DAC, also known as Mod GRF 1-29) alongside a selective ghrelin-receptor secretagogue (Ipamorelin) — the two peptides most frequently studied together in growth-hormone research.
- US-fulfilled, fast shipping: Domestic inventory, COA included, RUO documentation in every order.
Frequently Asked Questions
What’s actually in the vial?
5mg of CJC-1295 No DAC (Mod GRF 1-29) plus 5mg of Ipamorelin, lyophilized together — 10mg total peptide content per vial. The two compounds are blended at a fixed 1:1 weight ratio so every reconstituted aliquot delivers equal parts of each.
Is this the “with DAC” or “no DAC” version of CJC-1295?
No DAC. The CJC-1295 in this blend is the short-acting Modified GRF 1-29 form (no Drug Affinity Complex modification). If you need the long-acting, albumin-bound CJC-1295 With DAC, it’s available as a separate product.
How do I reconstitute the blend?
Add 2mL of bacteriostatic water for a clean 5mg/mL combined concentration (2.5mg/mL of each peptide). Direct the solvent stream along the inner wall of the vial and gently swirl until fully dissolved. Do not shake or vortex — gentle inversion only.
How is it stored?
Store the lyophilized vial at -20°C for long-term storage or 2–8°C for short-term use within 4 weeks. After reconstitution, refrigerate at 2–8°C and use within 28 days. Protect from light. Don’t freeze a reconstituted vial — ice crystals damage peptide structure.
Can I buy CJC-1295 No DAC and Ipamorelin separately?
Yes. Both are available as individual products in the Peptideware catalog: CJC-1295 No DAC 10mg and Ipamorelin 10mg. The blend is for researchers who plan to use both together and want the convenience of a single pre-mixed vial.
Why is this combination so commonly studied together?
The two peptides target different receptor systems on the pituitary: CJC-1295 (No DAC) is a GHRH analog that engages the GHRH receptor, while Ipamorelin is a selective ghrelin-receptor secretagogue. Researchers studying growth-hormone release pathways frequently use them together to investigate dual-receptor stimulation in published preclinical models.
What purity does each component meet?
CJC-1295 (No DAC) and Ipamorelin are each independently HPLC-verified at ≥99% purity before being combined into the blend. A Certificate of Analysis is available for each batch.
Further Reading
What’s in the Blend
The CJC-1295 + Ipamorelin Blend is a pre-mixed lyophilized vial containing two of the most-studied research peptides in growth-hormone investigation, combined in a fixed 1:1 ratio for single-vial convenience.
- CJC-1295 (No DAC) — 5mg: A synthetic 29-amino-acid analog of growth hormone-releasing hormone (also known as Modified GRF 1-29). Studied for its role in stimulating natural pulsatile GH release through pituitary GHRH receptors.
- Ipamorelin — 5mg: A selective pentapeptide growth hormone secretagogue that engages the ghrelin receptor. Frequently studied alongside GHRH analogs in published growth-hormone research.
This is the short-acting (No DAC) form of CJC-1295 — for the long-acting albumin-bound version, see CJC-1295 With DAC.
This research peptide blend undergoes rigorous quality control and stability testing to ensure maximum integrity for scientific applications. Each component is independently manufactured under strict laboratory conditions and verified through independent laboratory analysis before formulation.⚠️ FOR RESEARCH PURPOSES ONLY
This product is strictly for in-vitro laboratory research, analysis, and development. It is not intended for human consumption, injection, cosmetic use, or therapeutic use. This blend is not a drug.
Technical Specifications
- Total Concentration: 10mg per vial
- Composition:
- CJC-1295 (No DAC): 5mg (Modified GRF 1-29, 29-amino-acid GHRH analog)
- Ipamorelin: 5mg (5-amino-acid selective GH secretagogue)
- Ratio: Fixed 1:1 (50% / 50% by mass)
- Appearance: White lyophilized powder
- Purity: ≥99% (HPLC verified for each individual component before formulation)
- Recommended Reconstitution: 2mL bacteriostatic water for a 5mg/mL total concentration (2.5mg/mL of each peptide).
Storage & Handling
Peptides require careful storage to maintain their integrity and research effectiveness. Lyophilized peptides should be stored in a cold, dry, dark environment to prevent degradation. For short-term use within 4 weeks, storage at 4°C is sufficient, while long-term storage requires temperatures below -20°C or -80°C for extended periods up to 2 years. Always protect peptides from light exposure and avoid repeated freeze-thaw cycles, which can compromise structural integrity and research results.
